In-vitro activity of temafloxacin against anaerobic bacteria: a comparative study
- PMID: 1664827
- DOI: 10.1093/jac/28.suppl_c.25
In-vitro activity of temafloxacin against anaerobic bacteria: a comparative study
Abstract
The antimicrobial activity of temafloxacin for 328 anaerobic bacteria was determined and compared to that of cefotetan, cefoxitin, ciprofloxacin and metronidazole. The Wadsworth agar dilution technique using Brucella-lysed sheep blood agar was used throughout. At the recommended breakpoint concentration 4 mg/L, temafloxacin inhibited 60/62 (97%) of the isolates of Bacteroides fragilis and 82/87 (94%) of the isolates of other species of the B. fragilis group. Ninety-six percent of the 24 isolates of Peptostreptococcus, 97% of the 31 isolates of other Bacteroides species and 88% of 66 isolates of Fusobacterium species were also inhibited by 4 mg/L temafloxacin. Metronidazole (breakpoint 16 mg/L) had a broader spectrum of activity than temafloxacin (judged by the percentage of strains tested susceptible at the breakpoints employed) with the exception of non-sporing Gram-positive bacilli. The cephalosporins tested (breakpoint 32 mg/L) had a narrower spectrum of activity. Ciprofloxacin (breakpoint 2 mg/L) was the least effective agent against the majority of the anaerobes tested.
Similar articles
-
In vitro activities of three of the newer quinolones against anaerobic bacteria.Antimicrob Agents Chemother. 1992 Jan;36(1):239-43. doi: 10.1128/AAC.36.1.239. Antimicrob Agents Chemother. 1992. PMID: 1317149 Free PMC article.
-
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.J Antimicrob Chemother. 1994 Oct;34(4):579-84. doi: 10.1093/jac/34.4.579. J Antimicrob Chemother. 1994. PMID: 7868409
-
In vitro activity of Bay Y3118 against anaerobic bacteria.Antimicrob Agents Chemother. 1993 Nov;37(11):2509-13. doi: 10.1128/AAC.37.11.2509. Antimicrob Agents Chemother. 1993. PMID: 8285647 Free PMC article.
-
Patterns of susceptibility to fluoroquinolones among anaerobic bacterial isolates in the United States.Clin Infect Dis. 1993 Jun;16 Suppl 4:S377-81. doi: 10.1093/clinids/16.supplement_4.s377. Clin Infect Dis. 1993. PMID: 8324151 Review.
-
Temafloxacin: an overview.Am J Med. 1991 Dec 30;91(6A):166S-172S. doi: 10.1016/0002-9343(91)90332-r. Am J Med. 1991. PMID: 1662889 Review.
Cited by
-
Quinolone activity against anaerobes: microbiological aspects.Drugs. 1995;49 Suppl 2:76-80. doi: 10.2165/00003495-199500492-00012. Drugs. 1995. PMID: 8549420 Review.
-
New quinolones and gram-positive bacteria.Antimicrob Agents Chemother. 1994 Feb;38(2):163-9. doi: 10.1128/AAC.38.2.163. Antimicrob Agents Chemother. 1994. PMID: 8192436 Free PMC article. Review. No abstract available.
-
Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.Antimicrob Agents Chemother. 1993 May;37(5):1150-3. doi: 10.1128/AAC.37.5.1150. Antimicrob Agents Chemother. 1993. PMID: 8390810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources